| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.012 | 0.9 |